Important dates
Abstract submisson deadline:
31th July
07th August
Poster session
Poster session I. 11 September, 18:00-19:00
Poster session II. 12 September, 14:00-15:30
Poste session III. 12 September, 17:30-18:30
Poster presentations:
Posters are expected to be mounted on the opening day, before the poster session
and can remain displayed for 3 days, until the end of the Conference.
Please look for your poster stand according to the numbering below:
| P01 | RESOLVIN D1 AMELIORATES LIPOPOLYSACCHARIDE INDUCED BLOOD-BRAIN BARRIER DISRUPTION | Bulent Ahishali |
| P02 | ENDOTHELIAL OVEREXPRESSION OF ANGIOPOIETIN-2 EXERTS SEX-SPECIFIC EFFECTS ON CENTRAL NERVOUS SYSTEM AUTOIMMUNITY |
Rodrigo Alarcão |
| P03 | GROUP B STREPTOCOCCUS MEDIATED MIMIC OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR IMPACTS BLOOD BRAIN BARRIER INTEGRITY |
Natalie Alexande |
| P04 | TRANSCRIPTOME ANALYSIS OF THE ASTROCYTES INFECTED WITH THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 |
Mangesh Bhide |
| P05 | A HUMAN TISSUE IN VITRO MODEL OF THE BLOOD BRAIN BARRIER IN NEUROMYELITIS OPTICA SPECTRUM DISORDER |
Sarah Brandl |
| P06 | IMPACT OF ENDOTHELIN RECEPTOR ANTAGONISTS ON PERICYTE FUNCTION |
Genki Chikamatsu |
| P07 | EXAMINATION OF MAGNETIC NANOCARRIERS FOR TARGETED DELIVERY ACROSS THE BLOOD-BRAIN BARRIER USING A HUMAN CELL CULTURE MODEL |
Nárcisz Cser |
| P08 | CAPILLARY PERICYTES REGULATE VASCULAR TONE AND LOCAL BLOOD FLOW IN INFLAMMATION | Tamás Dudás |
| P09 | PERICYTES MEDIATE NEUROVASCULAR REMODELING IN CHRONIC ARTERIAL HYPERTENSION |
Ildikó R. Dunay |
| P10 | LONG-LASTING EFFECTS OF FETAL GROWTH RESTRICTION COMBINED TO EARLY POSTNATAL CHRONIC INFLAMMATION ON SELECTED PROPERTIES OF BLOOD BRAIN INTERFACES |
Cindy Durand |
| P11 | PROGESTERONE TREATMENT RESTORES BLOOD-BRAIN BARRIER FUNCTION AND IMPROVES LONG-TERM MEMORY AND LEARNING IN A RAT MODEL OF CHRONIC CEREBRAL HYPOPERFUSION |
Maydelín A. Espadín |
| P12 | AMYLOID-BETA IMMUNOTHERAPY IN ALZHEIMER’S DISEASE: AN IN VITRO STUDY DEPICTING THE MOLECULAR MECHANISMS |
Natalia E Grzesik |
| P13 | EXPRESSION OF ALPHA SMOOTH MUSCLE ACTIN DECREASES WITH AGEING AND INCREASES UPON LUMEN OBSTRUCTION IN MOUSE BRAIN PERICYTES |
Fanni Gyõri |
| P14 | DOUBLE-STRANDED DNA SENSING CGAS-STING SIGNALING PATHWAY AND NEUROINFLAMMATION IN A RAT CO-CULTURE MODEL OF THE BLOOD-BRAIN BARRIER |
András Harazin |
| P15 | UNDERSTANDING ACTIVATION OF THE UNFOLDED PROTEIN RESPONSE AT THE BLOOD-BRAIN BARRIER DURING GROUP B STREPTOCOCCAL INFECTION |
Sarah F. Hathcock |
| P16 | N,N-DIMETHYLTRIPTAMINE REDUCES CEREBRAL ISCHEMIA-INDUCED INFLAMMATION OF THE NEUROVASCULAR UNIT |
Zsófia Hoyk |
| P17 | HUMAN IMMORTALIZED CELL-BASED BLOOD-BRAIN BARRIER MODELS ARE A USEFUL TOOL FOR EVALUATION OF BRAIN PERMEABILITY OF AAV VECTORS |
Ryuto Isogai |
| P18 | IN VIVO DELIVERY OF BBB-PERMEABLE CYCLIC PEPTIDE FUSED MONOCLONAL ANTIBODIES TO THE MOUSE BRAIN |
Shingo Ito |
| P19 | BRAIN PERICYTES ENHANCE THE EXPRESSION AND PLASMA MEMBRANE LOCALIZATION OF MFSD2A IN BRAIN ENDOTHELIAL CELLS THROUGH PDGF-BB/PDGFRΒ SIGNALING PATHWAY |
Takuro Iwao |
| P20 | MAPK SIGNALING AT THE BLOOD BRAIN BARRIER DURING COXSACKIEVIRUS B3 INFECTION |
Taryn E. Keyzer |
| P21 | THE TRYPTOPHAN-KYNURENINE PATHWAY- THERAPEUTIC STRATEGY FOR NEUROPROTECTION IN TAUOPATHIES |
Krutika Khiratkar |
| P22 | P-GLYCOPROTEIN DISRUPTION IN BLOOD-BRAIN BARRIER HOST CELLS AS A RESULT OF STREPTOCOCCUS AGALACTIAE VIRULENCE FACTOR |
Hallie E. Knight |
| P23 | CHARACTERIZATION OF A NEW HUMAN CO-CULTURE MODEL OF ENDOTHELIAL CELLS, PERICYTES AND BRAIN ORGANOIDS IN A MICROFLUIDIC DEVICE |
Anna E. Kocsis |
| P24 | INFLAMMATORY CHANGES OF CHOROID PLEXUS IN TAUOPATHIES |
Andrej Kovac |
| P25 | A BLOOD-BRAIN BARRIER MODEL FOR LIPOSOMAL DRUG TARGETING - CHARACTERISATION OF HIPSC-DERIVED ENDOTHELIAL CELLS FOR IN VITRO MODELLING OF THE BBB |
Leo König |
| P26 | ALTERED EXPRESSION OF PATTERN RECOGNITION RECEPTORS IN HUMAN ASTROCYTES CAUSED BY NEUROINVASIVE BACTERIA |
Katarína Kucková |
| P27 | INVESTIGATION OF BLOOD-BRAIN BARRIER CHANGES IN ACUTE PANCREATITIS: A CELL CULTURE AND CLINICAL STUDY |
Nóra Kucsápszky |
| P28 | BONE MARROW-DERIVED CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN STROKE: A PROXY OF NEUROVASCULAR UNIT REPAIR |
Eliana Lauranzano |
| P29 | ANTIDEPRESSANT DRUGS MODIFY THE PERMEABILITY OF A HUMAN BLOOD-BRAIN BARRIER CULTURE MODEL BY ALTERING MEMBRANE TRAFFICKING |
Lucien Lemaitre |
| P30 | TOWARD CREATING AN ORTHOGONAL BRAIN GATE: DEVELOPMENT OF SYNTHETIC RECEPTORS FOR THE TRANSPORT OF DRUGS ACROSS THE BLOOD-BRAIN BARRIER |
Eduardo Ruiz-López |
| P31 | EXPLORING THE INFLUENCE OF TAU PATHOLOGY ON LIPID METABOLISM |
Petra Majerová |
| P32 | VISUALIZING AND FUNCTIONAL ASSESSMENT OF IN VITRO COMPLEX BLOOD-BRAIN BARRIER |
Tomáš Maµarik |
| P33 | PNEUMOCOCCUS INITIATES PRO-INFLAMMATORY SIGNALING AND SUPPRESSES TIGHT JUNCTION EXPRESSION IN IPSC-DERIVED BRAIN-LIKE ENDOTHELIAL CELLS |
Henry D. Mauser |
| P34 | ALANINE AND GLUTATHIONE TARGETING OF DOPAMINE OR IBUPROFEN-COUPLED POLYPEPTIDE NANOCARRIERS ELEVATES CROSSING ACROSS THE BLOOD-BRAIN BARRIER AND PROTECTIVE EFFECTS |
Mária Mészáros |
| P35 | STREPTOCOCCUS AGALACTIAE EFFECT ON BREAST CANCER RESISTANCE PROTEIN IN BRAIN-LIKE ENDOTHELIAL CELLS |
Alexandra E Meyer |
| P36 | EFFECTS OF PILT KNOCKOUT ON BLOOD-BRAIN BARRIER INTEGRITY IN VITRO |
Junqiao Mi |
| P37 | CHARACTERIZATION OF THE APPLICATION POTENTIALS OF MULTICELLULAR SPHEROIDAL HUMAN BLOOD-BRAIN BARRIER MODELS FOR STUDYING THE DEVELOPMENT OF BRAIN-PENETRATING DDS CARRIERS |
Seiya Ohki |
| P38 | MICROVASCULAR DYSFUNCTION AND CXCL12/PI3K/CREB SIGNALING MEDIATES HIPPOCAMPAL NEUROGENESIS POST- STROKE IN CEREBRAL AMYLOID ANGIOPATHY |
Olivia M. Osborne |
| P39 | STRONG INDUCTION OF IP-10 AND RANTES IN HUMAN BRAIN PERICYTES DESPITE WEAK INFECTION BY TICK BORNE ENCEPHALITIS VIRUS |
Martin Palus |
| P40 | PROTECTION OF THE BLOOD-BRAIN BARRIER AS A THERAPEUTIC TARGET IN THE CELL CULTURE MODEL OF ISCHEMIC STROKE |
Koppány Párdi |
| P41 | ENDOTHELIN RECEPTOR ANTAGONISM FOR MODULATION OF BLOOD-BRAIN BARRIER EFFLUX TRANSPORT |
Geoffrey Pecar |
| P42 | MODELING THE MOUSE BLOOD-BRAIN BARRIER: A SIMPLE METHOD FOR GENERATING MOUSE BRAIN ENDOTHELIAL CELL MONOLAYERS |
Alberte B. V. Pedersen |
| P43 | UTILIZATION OF THE YEAST TWO-HYBRID SYSTEM FOR THE DISCOVERY OF NOVEL TAU INTERACTION PARTNERS |
Karoline Pichlerová |
| P44 | CORTICAL PLASTICITY IS ASSOCIATED WITH BLOOD-BRAIN-BARRIER MODULATION | Ofer Prager |
| P45 | A PERSONALIZED AND BIOMIMETIC MODEL OF BLOOD BRAIN BARRIER TO EXPLORE AUTOLOGOUS LEUKOCYTES MIGRATION IN MULTIPLE SCLEROSIS |
Margherita M Ravanelli |
| P46 | TRANSPORT CHARACTERISTICS OF A BLOOD-BRAIN BARRIER-PERMEABLE CYCLIC PEPTIDE-FUSED MONOCLONAL ANTIBODIES IN IN VITRO BLOOD-BRAIN BARRIER MODELS |
Koki Sasaki |
| P47 | HIV ALTERS GAP JUNCTION COMMUNICATION IN LATENTLY INFECTED BLOOD-BRAIN BARRIER PERICYTES |
Sarah Schmidlin |
| P48 | DOES ALTERED OF EXPRESSION OF TJPS ACCOUNT FOR BBB LEAKINESS IN THE PRECUNEUS IN AD? |
Selvi Ince |
| P49 | DYNAMIC CONTRAST-ENHANCED MRI REVEALS BLOOD-BRAIN BARRIER DYSFUNCTION IN NEUROLOGICAL DISORDERS: INSIGHTS FROM A MULTI-CENTER STUDY | Sheizaf Shpilberg |
| P50 | TRAUMATIC BRAIN INJURY INDUCES SENESCENCE IN CELLS OF THE NEUROVASCULAR UNIT |
Tejal Shreeya |
| P51 | METHAMPHETAMINE ACTIVATES INFLAMMATION AND NEURODEGENERATIVE CHANGES IN C57BL/6 MICE BYPASSING THE NLRP3 INFLAMMASOME. |
M. Smolarz |
| P52 | CHRONIC INSTABILITY STRESS ALTERS BLOOD- BRAIN BARRIER COMPONENTS AND BEHAVIOUR OF ADULT FEMALES RATS IN EXPOSITION TIME MANNER |
Anna Solarz-Andrzejewska |
| P53 | DOSE-DEPENDENT INCREASE IN CXCL10 IN BRAIN ENDOTHELIAL CELLS AND GLIA FOLLOWING PERIPHERAL INFLAMMATION: POSSIBLE BIOMARKER FOR CEREBROVASCULAR INJURY? |
Helen B. Stolp |
| P54 | IN VIVO DISTRIBUTION OF ELETRIPTAN AND SUMATRIPTAN WITH LINKAGE TO PREDICTED TARGET ENGAGEMENT IN THE CNS AND PNS |
Nana Svane |
| P55 | INVESTIGATION OF DEXAMETHASONE LOADED POLYMER MICELLES ON THE CULTURE MODEL OF NASAL EPITHELIUM AND THE BLOOD-BRAIN BARRIER |
Milán Szántó |
| P56 | THE HISTONE DEACETYLASE INHIBITOR SUBEROYLANILIDE HYDROXAMIC ACID PROMOTES BLOOD-BRAIN BARRIER PROTECTION DURING REPERFUSION IN A CELL CULTURE MODEL OF ISCHEMIC STROKE |
Anikó Szecskó |
| P57 | BIODISTRIBUTION OF MODIFIED ISCHEMIC STROKE NEUROPROTECTIVE TAT-NR2B9C PEPTIDES UNVEILED A SEX SPECIFIC BRAIN UPTAKE FAVORING FEMALE BRAINS |
Maria Thaysen |
| P58 | EFFECTS OF HSPB1-OVEREXPRESSION ON INFLAMMATION AND GLIAL ACTIVATION IN A MOUSE MODEL OF ALZHEIMER’S DISEASE |
Melinda E. Tóth |
| P59 | EFFECTS OF CONTRAST AGENTS USED IN MEDICAL IMAGING ON THE BLOOD-BRAIN BARRIER |
Judit P. Vigh |
| P60 | ESTROGEN SIGNALING CONTRIBUTES TO GROUP B STREPTOCOCCAL DISRUPTION AND INVASION OF BRAIN ENDOTHELIAL CELLS |
Nadine Vollmuth |
| P61 | METHAMPHETAMINE NEGATIVELY AFFECTS THE FUNCTIONING OF MITOCHONDRIA IN ASTROCYTES. |
Gracjana Zaj±c |
| P62 | BLOOD-BRAIN BARRIER INTEGRITY SAFEGUARDED BY EXOGENOUS NICOTINAMIDES IN OXIDATIVE STRESS |
Antonio Zandona |
| P63 | FLUIDFM AND RESONANT WAVEGUIDE GRATING OPTICAL BIOSENSORS AS VALUABLE TOOLS IN BLOOD-BRAIN BARRIER RESEARCH | Imola Rajmon |
| P64 | IN VIVO EFFECT OF NOVEL PERIPHERALLY RESTRICTED AND MODERATELY BRAIN-PENETRANT CANNABINOID RECEPTOR 1 MODULATORS IN ALCOHOL USE DISORDER | Szabolcs Dvorácskó |